![David R. King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David R. King
Directeur/Membre du Conseil chez
Life Sciences Pennsylvania
Profil
David R.
King is the founder of BioRexis Pharmaceutical Corp.
(founded in 2002) where he held the title of Chief Executive Officer.
He is currently working at Life Sciences Pennsylvania as Vice Chairman since 2013.
Mr. King has also held former positions as Chief Executive Officer at Principia Pharmaceutical Corp.
in 2000, Executive Chairman at Inotek Pharmaceuticals Corp., Chairman at Diasome Pharmaceuticals, Inc., Independent Vice Chairman at Atonarp, Inc., Director at Cephalon, Inc., 3-Dimensional Pharmaceuticals, Inc., Morphotek, Inc., and Xencor, Inc., and as a Corporate Officer at Morgan, Lewis & Bockius LLP.
He was also President at Delsys Pharmaceutical Corp.
in 2001 and served as a Venture Partner at Quaker Partners Management LP from 2008 to 2013.
Mr. King received his undergraduate degree from the University of Pennsylvania and his graduate degree from Harvard Law School.
Postes actifs de David R. King
| Sociétés | Poste | Début |
|---|---|---|
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Directeur/Membre du Conseil | 21/06/2013 |
Anciens postes connus de David R. King
| Sociétés | Poste | Fin |
|---|---|---|
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Private Equity Investor | 01/03/2013 |
Innovation Philadelphia, Inc.
 Innovation Philadelphia, Inc. Investment ManagersFinance Innovation Philadelphia invests in companies located in the United States, primarily in the Greater Philadelphia region. The firm targets companies operating in the fields of technology & life sciences, biotechnology, pharmaceuticals and medical-devices sectors. It provides financing for pre-seed, seed and early stage capital requirements. | Directeur/Membre du Conseil | 31/03/2008 |
Delsys Pharmaceutical Corp.
 Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | President | 01/09/2001 |
Principia Pharmaceutical Corp
 Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and biopharmaceuticals for serious chronic diseases | Directeur Général | 01/09/2000 |
Atonarp, Inc.
 Atonarp, Inc. Medical SpecialtiesHealth Technology Develops and manufactures mass spectrometry and molecular sensing systems | Directeur/Membre du Conseil | - |
Formation de David R. King
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
3-Dimensional Pharmaceuticals, Inc.
 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and discovers drug candidates using its accelerated methodology for small molecule drug discovery | Health Technology |
Morphotek, Inc.
 Morphotek, Inc. BiotechnologyHealth Technology Develops oncology therapies | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Morgan, Lewis & Bockius LLP
 Morgan, Lewis & Bockius LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Principia Pharmaceutical Corp
Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and biopharmaceuticals for serious chronic diseases | Health Technology |
Delsys Pharmaceutical Corp.
Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Health Technology |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Innovation Philadelphia, Inc.
Innovation Philadelphia, Inc. Investment ManagersFinance Innovation Philadelphia invests in companies located in the United States, primarily in the Greater Philadelphia region. The firm targets companies operating in the fields of technology & life sciences, biotechnology, pharmaceuticals and medical-devices sectors. It provides financing for pre-seed, seed and early stage capital requirements. | Finance |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atonarp, Inc.
Atonarp, Inc. Medical SpecialtiesHealth Technology Develops and manufactures mass spectrometry and molecular sensing systems | Health Technology |
